换一批A phase I trial of topotecan and gemcitabine administered weekly for 3 consecutive weeks to patients with advanced tumors.
第一作者：
W,Sun
第一单位：
University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania 19104, USA.
作者：
医学主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);粒细胞缺乏(Agranulocytosis);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);脱氧胞苷(Deoxycytidine);疾病恶化(Disease Progression);剂量效应关系, 药物(Dose-Response Relationship, Drug);用药计划表(Drug Administration Schedule);女(雌)性(Female);人类(Humans);男(雄)性(Male);中年人(Middle Aged);肿瘤(Neoplasms);血小板减少(Thrombocytopenia);托泊替坎(Topotecan);治疗结果(Treatment Outcome)
DOI
10.1002/1097-0142(20010715)92:2<414::aid-cncr1337>3.0.co;2-w
PMID
11466697
发布时间
2022-12-07
- 浏览14
Cancer
414-9页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
